RAPID" GLUE COLLE INSTANTANÉE MULTIUSAGE

Hazard statements (CLP)

H315, H319, H335

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP)] Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

No additional information available

Hazard pictograms

GHS07

Signal word

Warning

Contains

ethyl 2-cyanoacrylate

Hazard statements

H315 - Causes skin irritation. H319 - Causes serious eye irritation. H335 - May cause respiratory irritation.

Precautionary statements

P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P260 - Do not breathe vapours. P264 - Wash hands thoroughly after handling. P271 - Use only outdoors or in a well-ventilated area. P280 - Wear protective gloves, eye protection/face protection.. P301+P310 - IF SWALLOWED: Immediately call a doctor, a POISON CENTER. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312 - Call a POISON CENTER, a doctor if you feel unwell. P337+P313 - If eye irritation persists: Get medical advice/attention. P403+P233 - Store in a well-ventilated place. Keep container tightly closed. P405 - Store locked up. P501 - Dispose of contents/container to a hazardous or special waste collection point.

Supplemental label elements

EUH202 - Cyanoacrylate. Danger. Bonds skin and eyes in seconds. Keep out of the reach of children. Child-resistant fastening : Not applicable Tactile warning : Not applicable

Other hazards which do not result in classification

Repeated or prolonged contact may cause allergic reactions in very susceptible persons. Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

H335 tract irritation Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP) : GHS07 Signal word (CLP)